Laidlaw Group’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,040	Closed	-$207K	–	76
2015 Q1	$207K	Hold	5,040	–	–	0.1%	76
2014 Q4	$205K	Buy	+5,040	New	+$205K	0.1%	80
2014 Q3	–	Sell	-5,040	Closed	-$234K	–	82
2014 Q2	$234K	Buy	+5,040	New	+$234K	0.12%	77